Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lung Neoplasms × Clindamycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Exanthema 1

Interventions

Carboplatin 106 Pemetrexed 74 Paclitaxel 58 Cisplatin 52 Erlotinib Hydrochloride 51 Radiotherapy 48 Docetaxel 43 Gemcitabine 41 Bevacizumab 41 pembrolizumab 30 Nivolumab 24 Radiosurgery 21 Etoposide 20 durvalumab 13 Cetuximab 13 Ipilimumab 12 Gefitinib 11 Vinorelbine 10 Taxes 10 Albumin-Bound Paclitaxel 10 osimertinib 9 Specimen Handling 9 Radiation 9 Magnetic Resonance Spectroscopy 9 vandetanib 8 Biopsy 8 Platinum 7 Drug Therapy 7 Dasatinib 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡